Marko Anderluh

Ljubljana, Slovenia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 83 publications

Sulfonylurea Bioisosteres of Sulfonic Acid in JFD 00458-Based ST6GAL1 Inhibitors Enhance Membrane Permeability.

Sulfonylurea Bioisosteres of Sulfonic Acid in JFD 00458-Based ST6GAL1 Inhibitors Enhance Membrane Permeability.

Journal: ChemMedChem

Published: May 27, 2026

Antibacterial and antibiofilm activities of novel bacterial topoisomerase inhibitors against Staphylococcus aureus and other clinically relevant pathogens.

Antibacterial and antibiofilm activities of novel bacterial topoisomerase inhibitors against Staphylococcus aureus and other clinically relevant pathogens.

Journal: European journal of medicinal chemistry

Published: March 05, 2026

Designing the DNA-Intercalating Moiety to Improve the Safety and Efficacy of Novel Bacterial Topoisomerase Inhibitors.

Designing the DNA-Intercalating Moiety to Improve the Safety and Efficacy of Novel Bacterial Topoisomerase Inhibitors.

Journal: Journal of medicinal chemistry

Published: February 06, 2026

β-1,4-galactosyltransferase 1 inhibitors modulate cellular N-glycan profiles.

β-1,4-galactosyltransferase 1 inhibitors modulate cellular N-glycan profiles.

Journal: Biotechnology progress

Published: January 14, 2026

Novel nastorazepide-based radioligands demonstrate effective cholecystokinin-2 receptor targeting with potential for theranostic applications.

Novel nastorazepide-based radioligands demonstrate effective cholecystokinin-2 receptor targeting with potential for theranostic applications.

Journal: Theranostics

Published: December 02, 2025

A nonavalent BODIPY with a multivalent arrangement of α-mannosides enables lectins recognition in fluorescence-based assays.

A nonavalent BODIPY with a multivalent arrangement of α-mannosides enables lectins recognition in fluorescence-based assays.

Journal: RSC chemical biology

Published: July 22, 2025

Mechanisms of beneficial effects of DPP-4 inhibitors as a promising perspective for the prevention/treatment of the disruption of cardio-cerebrovascular homeostasis.

Mechanisms of beneficial effects of DPP-4 inhibitors as a promising perspective for the prevention/treatment of the disruption of cardio-cerebrovascular homeostasis.

Journal: Frontiers in pharmacology

Published: June 06, 2025

OSMI-4-based PROTACs do not influence O-GlcNAc transferase and O-GlcNAcylation levels in cells.

OSMI-4-based PROTACs do not influence O-GlcNAc transferase and O-GlcNAcylation levels in cells.

Journal: RSC advances

Published: April 22, 2025

Author Correction: Nanomolar inhibitor of the galectin-8 N-terminal domain binds via a non-canonical cation-π interaction.

Author Correction: Nanomolar inhibitor of the galectin-8 N-terminal domain binds via a non-canonical cation-π interaction.

Journal: Communications chemistry

Published: April 01, 2025

Design, synthesis, and evaluation of a novel fluorescent probe for competitive fluorescence polarization assay to screen galectin-8 inhibitors.

Design, synthesis, and evaluation of a novel fluorescent probe for competitive fluorescence polarization assay to screen galectin-8 inhibitors.

Journal: Acta pharmaceutica (Zagreb, Croatia)

Published: March 27, 2025

New Inhibitors of β-1,4-Galactosyltransferase I Discovered by Virtual Screening.

New Inhibitors of β-1,4-Galactosyltransferase I Discovered by Virtual Screening.

Journal: ChemMedChem

Published: November 08, 2024

Enhancing Antibacterial Efficacy: Combining Novel Bacterial Topoisomerase Inhibitors with Efflux Pump Inhibitors and Other Agents Against Gram-Negative Bacteria.

Enhancing Antibacterial Efficacy: Combining Novel Bacterial Topoisomerase Inhibitors with Efflux Pump Inhibitors and Other Agents Against Gram-Negative Bacteria.

Journal: Antibiotics (Basel, Switzerland)

Published: October 28, 2024

Showing 1-12 of 83

Last Updated: 09/26/2026